A family with nine siblings showing signs of Rothmund-Thomson syndrome with two being definitely diagnosed with the syndrome due to homozygous N-terminal mutation of RECQL4.

N‐terminal homozygous frameshift mutation RECQL4 gene Rothmund–Thomson type II syndrome (RTS2) biallelic mutations human mice

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 26 12 2023
revised: 05 06 2024
accepted: 02 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: epublish

Résumé

This study presents a family with nine children, two of them diagnosed with RTS2 using genetic testing. The other siblings show some of the RTS2 criteria and are suggestive of the syndrome. Such reports help physicians be more alert in dealing with cases of rare syndromes. Timely initiation of genetic counseling and testing once the first child was diagnosed with the syndrome could have prevented the birth of affected siblings by RTS2. Since RTS2 patients could have a severe clinical manifestation as osteosarcoma which probably leads to death at a young age, the importance of genetic testing is even more underlined.

Identifiants

pubmed: 39055085
doi: 10.1002/ccr3.9176
pii: CCR39176
pmc: PMC11268933
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e9176

Informations de copyright

© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The author(s) declare no competing interests.

Auteurs

Fatemeh Yadegari (F)

Genetics Department Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran.

Aseel Rashid Abed (AR)

Warith International Cancer Institute Karbala Iraq.

Widad Yadallah Abd Ali (WY)

Warith International Cancer Institute Karbala Iraq.

Haider Hamza Al-Abedi (HH)

Warith International Cancer Institute Karbala Iraq.

Shiva Zarinfam (S)

Genetics Department Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran.

Solaleh Aminian (S)

Genetics Department Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran.

Keivan Majidzadeh-A (K)

Genetics Department Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran.

Classifications MeSH